ACTYM THERAPEUTICS, INC.
Actym Therapeutics, based in Berkeley, CA, is a privately-held biotechnology company focused on discovery and development of novel immuno-oncology therapies to treat cancer. The company has developed an attenuated, microbial-based, immunotherapeutic technology platform called STACT (S. Typhimurium-Attenuated Cancer Therapy). In preclinical studies, STACT specifically enriches in many types of solid tumors and not in healthy tissue. Once there, STACT delivers multiplexed immuno-modulatory payload... s directly to tumor-resident immune cells. Many of these payload targets are of significant interest to the biopharmaceutical community but are intractable using conventional approaches due to systemic toxicities after intravenous dosing. Furthermore, STACT has been engineered to deliver payload combinations, which facilitates engagement of multiple biological pathways from a single therapy. In April of 2020, Actym raised $34 million in a Series A financing, co-led by Boehringer-Ingelheim Venture Fund and Panacea Venture Healthcare, with participation from Illumina Ventures, Korea Investment Partners, and JLO Ventures.
ACTYM THERAPEUTICS, INC.
Industry:
Biotechnology Medical Medical Device
Founded:
2017-05-01
Address:
Berkeley, California, United States
Country:
United States
Website Url:
http://www.actymthera.com
Total Employee:
11+
Status:
Active
Total Funding:
34 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress Content Delivery Network
Similar Organizations
Asklepios BioPharmaceutical
Asklepios BioPharmaceutical is a biotechnology company developing adeno-associated virus (AAV) gene therapies for genetic disorders.
Anchiano Therapeutics
Anchiano is a clinical-stage biopharmaceutical company focused on the discovery and development of novel therapies to treat cancer.
Capsulomics
Capsulomics Inc. is a life sciences company focused on the development and commercialization of diagnostic tests for cancer prevention.
Dice Therapeutics
Dice Therapeutics develops a transformative platform designed for the discovery of novel small molecules.
Northwest Biotherapeutics
Northwest Biotherapeutics is a biotechnology company focused on developing and commercializing immunotherapy products to treat cancer.
PIQUR Therapeutics
PIQUR Therapeutics is a Swiss pharmaceutical company focusing on the discovery and development of anti-cancer drugs.
Current Advisors List
Current Employees Featured
Founder
Investors List
Korea Investment Partners
Korea Investment Partners investment in Series A - Actym Therapeutics, Inc.
Illumina Ventures
Illumina Ventures investment in Series A - Actym Therapeutics, Inc.
JLo Ventures
JLo Ventures investment in Series A - Actym Therapeutics, Inc.
Boehringer Ingelheim Venture Fund
Boehringer Ingelheim Venture Fund investment in Series A - Actym Therapeutics, Inc.
Panacea Venture
Panacea Venture investment in Series A - Actym Therapeutics, Inc.
Intellectus Partners
Intellectus Partners investment in Seed Round - Actym Therapeutics, Inc.
Key Employee Changes
Date | New article |
---|---|
2021-11-11 | Actym Therapeutics Appoints Chan Whiting as Chief Development Officer |
Official Site Inspections
http://www.actymthera.com Semrush global rank: 2.87 M Semrush visits lastest month: 5.66 K
- Host name: unalocated.63.wixsite.com
- IP address: 185.230.63.107
- Location: Ashburn United States
- Latitude: 39.018
- Longitude: -77.539
- Metro Code: 511
- Timezone: America/New_York
- Postal: 20147